Paper Details

  1. Home
  2. Paper Details

Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review.

Author: BennettTrish, CaldwellPatrina, LaiElise, RamanGayathri, TunnicliffeDavid

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Solifenacin, an anticholinergic, is being investigated for its safety and tolerability in treating overactive bladder syndrome (OAB) in children. It offers an alternative to other therapies with potentially fewer anticholinergic side effects.
Paper Details　
Original Abstract of the Article :
Solifenacin is an anticholinergic that is used to treat overactive bladder syndrome (OAB) in children. It is important to ascertain the safety and tolerability of solifenacin in the paediatric population as solifenacin offers an alternative, is more bladder specific, and should have less anticholine...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jpurol.2022.09.014

データ提供：米国国立医学図書館（NLM）

A Safe Oasis for Children with Overactive Bladder

Overactive bladder (OAB) can be a disruptive condition for children, affecting their daily lives and well-being. This research reviews the safety and tolerability of solifenacin, an anticholinergic medication used to treat OAB, in children and adolescents. The authors systematically reviewed existing studies, examining the evidence for the safety and effectiveness of this medication in young patients. It's like finding a safe and comfortable oasis in the desert of OAB, providing relief and improved quality of life for children.

Solifenacin: A Potential Solution for Children with OAB

The review suggests that solifenacin may be a safe and effective treatment option for children with OAB. The evidence suggests that the medication is well-tolerated by young patients, offering relief from symptoms and improving their quality of life.

Navigating the Challenges of OAB in Children

This research highlights the importance of finding safe and effective treatments for children with OAB. By understanding the potential benefits and risks of medications like solifenacin, we can provide better care for young patients and help them navigate the challenges of this condition.

Dr. Camel's Conclusion

This review provides valuable information about the potential benefits and safety of solifenacin in children with OAB. By offering a safe and effective treatment option, we can help young patients overcome this challenging condition and experience a better quality of life.

Date :
  1. Date Completed 2023-02-07
  2. Date Revised 2023-03-27
Further Info :

Pubmed ID

36336627

DOI: Digital Object Identifier

10.1016/j.jpurol.2022.09.014

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.